Literature DB >> 1936826

Pancreatic ductal stones: frequency of successful endoscopic removal and improvement in symptoms.

S Sherman1, G A Lehman, R H Hawes, T Ponich, L S Miller, L B Cohen, P Kortan, G B Haber.   

Abstract

Pancreatic ductal stones may be responsible for attacks of acute pancreatitis (chronic relapsing pancreatitis) or exacerbations of chronic pain in patients with chronic pancreatitis. This study was undertaken to identify those patients with predominantly main pancreatic duct stones most amenable to endoscopic removal and to determine the effects on the patients' clinical course with such removal. Thirty-two patients with ductographic evidence of chronic pancreatitis and pancreatic duct stones underwent attempted endoscopic removal. Of the patients, 71.9% had complete or partial stone removal and 67.7% improved after endoscopic therapy. Symptomatic improvement was most evident in the group of patients with chronic relapsing pancreatitis. Factors favoring stone removal included (1) three or less stones, (2) stones confined to the head and/or body of the pancreas, (3) absence of a downstream stricture, (4) stone diameter less than or equal to 10 mm, and (5) absence of impacted stones. After successful stone removal, 25% of patients had regression of the ductographic changes of chronic pancreatitis and 41.7% had a decrease in the main pancreatic duct diameter. The only complication from therapy was mild pancreatitis in 8.2%. These data suggest that removal of pancreatic duct stones may result in symptomatic improvement. A longer follow-up will be necessary to determine whether endoscopic success results in long-standing clinical improvement and/or permanent regression of the morphologic changes of chronic pancreatitis.

Entities:  

Mesh:

Year:  1991        PMID: 1936826     DOI: 10.1016/s0016-5107(91)70818-3

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  24 in total

Review 1.  Endoscopic retrograde cholangiopancreatography in chronic pancreatitis.

Authors:  Peter J Bolan; Aaron S Fink
Journal:  World J Surg       Date:  2003-10-16       Impact factor: 3.352

2.  Extracorporeal shock wave lithotripsy (ESWL) for large pancreatic stones: are these shocks worth while?

Authors:  Deepak Kumar Bhasin; Surinder S Rana
Journal:  Indian J Gastroenterol       Date:  2010-08-12

3.  What is the role of endotherapy in chronic pancreatitis?

Authors:  Haritha Avula; Stuart Sherman
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 4.  Endotherapy for chronic pancreatitis.

Authors:  R A Kozarek; L W Traverso
Journal:  Int J Pancreatol       Date:  1996-04

Review 5.  Current status of endotherapy for chronic pancreatitis.

Authors:  Andrew Boon Eu Kwek; Tiing Leong Ang; Amit Maydeo
Journal:  Singapore Med J       Date:  2014-12       Impact factor: 1.858

6.  Endoscopic therapy is effective for patients with chronic pancreatitis.

Authors:  Bridger Clarke; Adam Slivka; Yutaka Tomizawa; Michael Sanders; Georgios I Papachristou; David C Whitcomb; Dhiraj Yadav
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-13       Impact factor: 11.382

Review 7.  Endoscopic therapy in chronic pancreatitis.

Authors:  Damien Meng Yew Tan; Stuart Sherman
Journal:  Korean J Intern Med       Date:  2011-11-28       Impact factor: 2.884

8.  Long term follow up of patients with chronic pancreatitis and pancreatic stones treated with extracorporeal shock wave lithotripsy.

Authors:  H E Adamek; R Jakobs; A Buttmann; M U Adamek; A R Schneider; J F Riemann
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 9.  Endoscopic therapy for chronic pancreatitis: technical success, clinical outcomes, and complications.

Authors:  Lukasz M Kowalczyk; Peter V Draganov
Journal:  Curr Gastroenterol Rep       Date:  2009-04

10.  Endoscopic management of chronic pancreatitis.

Authors:  Veeral M Oza; Michel Kahaleh
Journal:  World J Gastrointest Endosc       Date:  2013-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.